Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Titrimetric Assay Development for Alkalinity – V 2.0

Posted on By

Analytical Method Development: Titrimetric Assay Development for Alkalinity – V 2.0

SOP for Titrimetric Assay Development for Alkalinity in the AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/045/2025
Supersedes SOP/AMD/045/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the systematic approach to developing and validating titrimetric methods for determining alkalinity in APIs, excipients, and pharmaceutical formulations. The procedure ensures accurate, repeatable,

and compliant results consistent with pharmacopeial standards.

2. Scope

This SOP is applicable to all titrimetric assays designed to quantify alkalinity in drug substances, raw materials, solutions, and finished products analyzed within the Analytical Method Development (AMD) laboratory.

3. Responsibilities

  • Analytical Scientist: Executes method development and documents results accurately.
  • Reviewer: Reviews calculations, confirms method suitability, and checks precision.
  • QA: Verifies documentation, reviews validation records, and ensures regulatory compliance.
  • Head – AMD: Approves the developed method and validation summary for use.
See also  Analytical Method Development: Deviation Management during Method Development - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that alkalinity assays are scientifically developed, validated, and included in product development files or technology transfer documents.

5. Procedure

5.1 Method Selection and Design

  1. Assess the nature of the alkaline component (e.g., sodium carbonate, hydroxides).
  2. Select titrant:
    • Standard 0.1 N HCl is commonly used for alkalinity titration.
  3. Choose an appropriate indicator:
    • Methyl orange (for strong bases)
    • Bromocresol green (for bicarbonates)
  4. Design the method as per compendial guidelines or based on chemical structure of analyte.

5.2 Sample Preparation

  1. Weigh accurately 0.2–1.0 g of the sample into a titration flask.
  2. Dissolve in 50–100 mL of CO2-free purified water.
  3. Filter if necessary to obtain a clear solution.
  4. Record all preparation details in Annexure-1: Sample Preparation Log.

5.3 Titration Procedure

  1. Add 2–3 drops of indicator to the sample solution.
  2. Titrate with standard 0.1 N HCl using a calibrated burette until the endpoint is reached (color change noted).
  3. Perform at least three concordant titrations (difference ≤ 0.1 mL).
  4. Calculate alkalinity using the formula:
    Alkalinity (%) = (V × N × Eq. Wt × 100) / Sample Weight (mg)
    
  5. Document titration data in Annexure-2: Titrimetric Data Sheet.
See also  Analytical Method Development: Reference Standard Qualification for AMD - V 2.0

5.4 Method Optimization

  1. Optimize:
    • Titrant concentration (0.05 N, 0.1 N)
    • Sample dilution and solvent system
    • Indicator selection and visual endpoint
  2. Evaluate:
    • Sharpness of endpoint
    • Repeatability of titration
  3. Capture optimization details in Annexure-3: Method Development Worksheet.

5.5 Method Validation

  1. Validate the method as per ICH Q2(R1):
  2. Specificity: Demonstrate absence of interference from excipients.
  3. Accuracy: Recovery should range from 98% to 102%.
  4. Precision: RSD ≤ 2.0% (repeatability and intermediate precision).
  5. Linearity: Evaluate across five concentration levels.
  6. Robustness: Assess impact of slight changes in titrant strength or temperature.
  7. Summarize data in Annexure-4: Validation Report.

6. Abbreviations

  • AMD: Analytical Method Development
  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Preparation Log – Annexure-1
  2. Titrimetric Data Sheet – Annexure-2
  3. Method Development Worksheet – Annexure-3
  4. Validation Report – Annexure-4
See also  Analytical Method Development: Selection of Analytical Techniques - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <401> – Alkalinity Assays
  • Ph. Eur. General Methods
  • 21 CFR Part 211 – Laboratory Controls

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Preparation Log

Date Sample Name Weight (mg) Solvent Prepared By
02/05/2025 API-B 500 CO2-free water Rajesh Kumar

Annexure-2: Titrimetric Data Sheet

Trial Volume of HCl (mL) Normality Sample Weight Alkalinity (%)
1 10.2 0.1 500 0.82

Annexure-3: Method Development Worksheet

Parameter Condition Observation Conclusion
Indicator Methyl orange Sharp pink endpoint Suitable

Annexure-4: Validation Report

Parameter Acceptance Criteria Results Status
Precision RSD ≤ 2% 1.6% Pass
Accuracy 98–102% 99.2% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated validation parameters and included CO2-free solvent instructions GMP Compliance
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Periodic Review of Expression Cell Lines – V 2.0
Next Post: API Manufacturing: SOP for In-Process Filtrate Clarity Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version